Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 22 studies | 24% ± 8% | |
capillary endothelial cell | 10 studies | 24% ± 6% | |
vein endothelial cell | 9 studies | 25% ± 13% | |
astrocyte | 5 studies | 38% ± 15% | |
basal cell | 4 studies | 34% ± 16% | |
glomerular endothelial cell | 3 studies | 31% ± 0% | |
epithelial cell | 3 studies | 22% ± 4% | |
endothelial cell of vascular tree | 3 studies | 26% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 11143.17 | 1809 / 1809 | 83% | 39.12 | 394 / 472 |
breast | 100% | 2676.82 | 459 / 459 | 83% | 21.19 | 933 / 1118 |
esophagus | 99% | 2631.29 | 1436 / 1445 | 81% | 41.65 | 148 / 183 |
uterus | 99% | 3602.85 | 169 / 170 | 79% | 27.82 | 364 / 459 |
lung | 99% | 3194.35 | 575 / 578 | 73% | 27.66 | 848 / 1155 |
kidney | 93% | 1045.66 | 83 / 89 | 77% | 24.11 | 695 / 901 |
bladder | 90% | 1358.67 | 19 / 21 | 45% | 12.59 | 229 / 504 |
prostate | 83% | 779.58 | 203 / 245 | 41% | 3.34 | 205 / 502 |
intestine | 83% | 2084.44 | 805 / 966 | 31% | 6.49 | 165 / 527 |
thymus | 58% | 545.40 | 382 / 653 | 49% | 9.10 | 299 / 605 |
adipose | 100% | 3434.23 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2546.81 | 1320 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 40.84 | 42 / 45 |
heart | 92% | 1528.31 | 792 / 861 | 0% | 0 | 0 / 0 |
ovary | 19% | 190.67 | 35 / 180 | 71% | 12.77 | 305 / 430 |
pancreas | 1% | 8.77 | 3 / 328 | 81% | 14.79 | 144 / 178 |
stomach | 32% | 330.81 | 115 / 359 | 32% | 4.68 | 92 / 286 |
brain | 25% | 199.76 | 670 / 2642 | 27% | 3.67 | 191 / 705 |
adrenal gland | 24% | 171.45 | 63 / 258 | 5% | 0.50 | 12 / 230 |
liver | 1% | 14.02 | 2 / 226 | 27% | 3.45 | 109 / 406 |
spleen | 26% | 181.23 | 63 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 20% | 3.05 | 16 / 80 |
muscle | 17% | 135.61 | 135 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 15% | 307.66 | 136 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.33 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0061045 | Biological process | negative regulation of wound healing |
GO_0072675 | Biological process | osteoclast fusion |
GO_0045616 | Biological process | regulation of keratinocyte differentiation |
GO_0010839 | Biological process | negative regulation of keratinocyte proliferation |
GO_2000647 | Biological process | negative regulation of stem cell proliferation |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0001942 | Biological process | hair follicle development |
GO_0043616 | Biological process | keratinocyte proliferation |
GO_0072089 | Biological process | stem cell proliferation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0031092 | Cellular component | platelet alpha granule membrane |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0098552 | Cellular component | side of membrane |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0050431 | Molecular function | transforming growth factor beta binding |
Gene name | CD109 |
Protein name | CD109 antigen CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109) |
Synonyms | CPAMD7 |
Description | FUNCTION: Modulates negatively TGFB1 signaling in keratinocytes. . |
Accessions | ENST00000287097.6 [Q6YHK3-1] ENST00000437994.6 [Q6YHK3-4] F1C639 ENST00000422508.6 [Q6YHK3-2] Q6YHK3 |